Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Methods in Enzymology|May 10, 2012
Chitosan-based nanoparticles as a hepatitis B antigen delivery systemFilipa Lebre, Dulce Bento, Sandra Jesus, et al.
Pharmaceutics|February 13, 2019
Chitosan Plus Compound 48/80: Formulation and Preliminary Evaluation as a Hepatitis B Vaccine AdjuvantDulce Bento, Sandra Jesus, Filipa Lebre, et al.
Pharmaceutical Research|December 3, 2009
Mucosal vaccines: recent progress in understanding the natural barriersOlga Borges, Filipa Lebre, Dulce Bento, et al.
The Journal of Pharmacy and Pharmacology|February 27, 2019
Easy and effective method to generate endotoxin-free chitosan particles for immunotoxicology and immunopharmacology studiesFilipa Lebre, Ed C Lavelle, Olga Borges
Pharmaceutics|August 28, 2025
Yeast-Derived Glucan Particles: Biocompatibility, Efficacy, and Immunomodulatory Potential as Adjuvants and Delivery SystemsJoão Panão-Costa, Mariana Colaço, Sandra Jesus, et al.
Vaccine|June 19, 2015
Effect of particulate adjuvant on the anthrax protective antigen dose required for effective nasal vaccinationDulce Bento, Herman F Staats, Olga Borges
AAPS Pharmscitech|March 8, 2013
Validation of a new 96-well plate spectrophotometric method for the quantification of compound 48/80 associated with particlesDulce Bento, Gerrit Borchard, Teresa Gonçalves, et al.
Pharmaceutical Research|November 20, 2010
Progress towards a needle-free hepatitis B vaccineFilipa Lebre, Gerrit Borchard, Maria Conceição Pedroso de Lima, et al.
International Journal of Pharmaceutics|March 15, 2024
Exploring the immunomodulatory properties of glucan particles in human primary cellsSandra Jesus, João Panão Costa, Mariana Colaço, et al.
International Journal of Pharmaceutics|June 2, 2026
Intranasal administration of a DNA vaccine complexed with sugar-functionalized chitosan induces protective immunity against SARS-CoV-2 in miceMariana Colaço, João Panão-Costa, Filipa Lebre, et al.
Pageof 8